Does Tesamorelin Increase Blood Pressure?

Tesamorelin can increase blood pressure, but the effect is usually modest. In clinical trials of tesamorelin (brand name Egrifta) for HIV-associated visceral fat, average blood pressure changes were small, while a minority of participants — often those with existing hypertension or visible fluid retention — saw clinically meaningful rises. In short, the answer to does tesamorelin raise blood pressure is a qualified yes: possible, usually mild, and highly individual.

Tesamorelin is a synthetic growth hormone–releasing hormone (GHRH) analog. It is FDA-approved for reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy, and it is used off-label in some body-composition and anti-aging protocols. Because it changes growth hormone and IGF-1 signaling, it can affect fluid balance — and fluid balance is one of the levers your body uses to set blood pressure.

The Short Answer on Tesamorelin and Blood Pressure

Most published data suggest that tesamorelin raises blood pressure slightly, if at all, on average. That average hides a lot of variation. Some users see no change, some see a few points, and some see a rise large enough to require a medication adjustment.

Two things are often true at the same time. Tesamorelin can promote sodium and water retention, which pushes blood pressure up. It also reduces visceral fat and, in some patients, body weight — which can push blood pressure down. Which effect wins depends on the person.

How Tesamorelin Could Raise Blood Pressure

The main pathway runs through growth hormone and IGF-1. Tesamorelin signals the pituitary to release more growth hormone, which increases IGF-1 production in the liver. Both hormones promote sodium reabsorption in the kidney and fluid retention in the tissues, and that expanded fluid volume can raise blood pressure.

Another common question, does tesamorelin increase igf-1, matters here because IGF-1 is one of the primary drivers of this effect. Prescribers typically monitor IGF-1 levels during treatment and lower the dose if levels climb too high.

Other contributors include:

• Peripheral edema. Swelling in the hands, feet, or ankles is a visible sign of fluid retention and often travels with higher blood pressure.
• Sleep apnea. Growth hormone can worsen sleep-disordered breathing in susceptible people, and untreated sleep apnea raises blood pressure.
• Injection-related stress and pain. Minor, but acute pain and anxiety can transiently elevate readings.

What Clinical Trials and Prescribing Data Show

In the phase 3 trials that supported FDA approval, participants received tesamorelin 2 mg daily for 26 weeks. Mean changes in systolic and diastolic blood pressure were small, and hypertension was reported in only a subset of patients. Longer open-label follow-up showed a similar pattern, with some participants starting or intensifying antihypertensive therapy.

The practical takeaway: tesamorelin is not a drug that reliably spikes blood pressure in everyone, but it is a drug that can do so in some people. That is why baseline and follow-up blood pressure checks are part of responsible use.

Tesamorelin vs. Other Peptides and GLP-1s

It helps to compare tesamorelin with other compounds people commonly ask about.

The same logic applies if you are asking does sermorelin raise blood pressure — the mechanism is nearly identical because both drugs act on the growth hormone axis.

By contrast, a different drug class tends to move blood pressure in the other direction, and the research on does semaglutide lower blood pressure generally points to modest reductions of a few points, largely through weight loss.

Who Is Most at Risk for a Blood Pressure Increase

• People with existing hypertension, especially those already taking two or more medications
• Adults over 60, whose blood vessels are less flexible
• Anyone with heart failure, kidney disease, or a history of edema
• People taking NSAIDs, corticosteroids, or other drugs that cause fluid retention
• Users who mount a strong IGF-1 response to tesamorelin
• People with untreated obstructive sleep apnea

If you have high blood pressure, tesamorelin is not automatically off the table. It does mean your clinician should review your regimen, set a monitoring plan, and know what to do if your numbers drift upward.

How to Monitor and Manage Blood Pressure on Tesamorelin

1. Get a baseline. Take readings at home twice daily for a week before you start, using a validated upper-arm cuff.
2. Recheck early. Repeat the same routine two to four weeks after starting, then again at three months.
3. Keep a log. A simple spreadsheet with date, time, systolic, diastolic, and swelling notes is enough.
4. Watch for fluid retention. New ankle swelling, tight rings, or a rapid gain of several pounds in a few days deserves a call to your clinician.
5. Report meaningful changes. A sustained rise of 10 mm Hg or more from baseline, or any reading at or above 140/90, should be evaluated.
6. Ask about dose and IGF-1. Dose reduction or discontinuation is often enough to bring blood pressure back down.

Unlike questions about drug detection — for example, does semaglutide show up in blood work — blood pressure is something you can measure yourself, cheaply and accurately, at home.

When to Talk to a Healthcare Professional

Contact a clinician promptly if you develop persistent headaches, blurred vision, chest pain, shortness of breath, or swelling that worsens over days. These can signal a blood pressure problem that needs treatment rather than watchful waiting.

Tesamorelin is a prescription medication with real effects on hormone and fluid balance. It should be used under medical supervision, with periodic IGF-1 and blood pressure monitoring, and it is not appropriate during pregnancy or with active malignancy.

Bottom line: tesamorelin blood pressure effects are real but usually modest, and the risk is manageable with baseline readings, early follow-up, and a clinician who adjusts the plan when needed.